The proliferation-promoting activity of sera obtained from pigs before and after porcine growth hormone injections was tested in a muscle cell culture bioassay. For 3 d, purified porcine growth hormone (pGH) was administered by intramuscular injection to crossbred barrows. Two levels of pGH were administered: 18 /~g pGH,kg -1 body weight'd -a (low dose) or 143 /ag pGH'kg -~ body weight.d -~ (high dose). Multiple blood samples were withdrawn from jugular catheters for 3 d prior to the injection, during tke injection period and for 6 d after the last injection. Although serum pGll levels in low-dose pigs were raised from two to three times pre-injection levels, there was no significant change in serum proliferation-promoting activity or somatomedin-C (SmC), insulin or cortisol levels during or after administration of pGH. In contrast, the proliferation-promoting activity of sera obtained during and after the high-dose pGH injections was higher (I'<.005) than the pre-injection levels. Serum pGH levels were increased approximately 30-fold by 4 h after each injection, and increases in SmC levels were observed 10 to 16 h after the pGH injection. During the injection period SmC levels increased from 1.7 to 4 times pre-injection levels. Insulin and cortisol levels did not change significantly during the 3-d treatment period. We believe that this muscle cell culture bioassay system will be a useful addition to traditional radioimmunoassays and whole animal studies in elucidating the mode of action of pGll in pituitary-intact swine.
I ntroduction
Incrcased understanding of the biological controls regulating muscle growth in meatproducing animals should enable us to utilizc biochemical methods to increase rate and efficiency of muscle production. Presumably, the endocrine system plays an important role in controlling muscle growth in meat-producing animals; hc~wever, relatively little is known about the role of specific hormones in this process. The ability to produce large quantities of growth hormone (GH) via recombinant DNA techniques has focused considerable attention on the anabolic effects of this peptide in meat-producing animals. Although there have a Published as paper no. 15161 of the scientific journal series of the Minnesota Agr. Exp. Sta. on research conducted under Minnesota Agr. . This work was supported by Monsanto Co., Minnesota Agr. Exp. Sta. and a grant from the Natl. Pork Producers Council.
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Received April 21, 1986 . Accepted September 18, 1986 been conflicting reports concerning the effect of exogenous GH on muscle growth in swine with normal endogenous GH levels (Turman and Andrews, 1955; [tenricson and Ullberg, 1960; Machlin, 1972; Baile et al., 1983; Chung et al., 1985) , it now appears that long-term injection of highly purified porcine growth hormone (pGH) increases muscling, decreases fat and improves feed efficiency in growing pigs (Machlin, 1972; Chung et al., 1985) . However, very little is known about the mechanism through which pGH affects muscle deposition in pituitary-intact swine. Additionally, we have little information about the effect of artificially increased GH levels on the concentrations of somatomedin or other hormones whose levels might be affected by this increasc. It is our belief that a well-characterized muscle cell culture system, which responds in an anabolic manner to sera from growth hormone-treated pigs, would be an extremely useful addition to traditional radioimmunoassays in elucidating the mode of action of GH. This bioassay system should allow identification of any biologically active factors (in addition to insulin-like growth factor l/somatomedin-C) that may play a rolc in the GH-mediated increases in muscle growth observed in GH-injected pigs.
623
J. An;m. Sci. 1987.64:623-632 Consequently, the objective of the present study was to characterize the response of a muscle cell culture bioassay (Kotts et al., 1987) to GH-induced changes in swine serum. The muscle cell culture bioassay measured the difference in proliferation-promoting activity between sera obtained from normal growing pigs before, during and after short-term pGH injection. Additionally, circulating levels of pGH, somatomedin-C (SMC), insulin and cortisol were examined to determine whether changes in levels of these hormones were related to changes in serum proliferation-promoting activity. This muscle cell culture bioassay system will be used in future studies of the mechanism by which pGH stimulates muscle growth in pituitary-intact swine.
Materials and Methods
Crossbred barrows (19 to 36 kg) from separate litters were individually penned and fed, ad libitum, a corn-soybean-based diet containing 21% protein.
Injection of Pigs with Porcine Growth Hormone (pGH).
The pGH s used for injection was lot ~t7024-C (specific activity = 1.5 U/mg) and that used for radioimmunoassay standard was lot APF 6400. Two studies were conducted. In the first study three pigs were injected intramuscularly once daily with 18 ttg pGH.kg--i.d -1 (low dose) and one pig was injected with 143 #g pGH-kg-l-d -i (high dose). In the second study, five pigs were injected with the high dose of pGH.
Catheters were inserted into both jugular veins and after a 24-d recovery period, 12-ml blood samples were removed from the catheters at 6-h intervals (0600, 1200, 1800 and 2400) throughout the duration of the study. Pre-injection blood samples were obtained on d 1 to 3 of each study. Injections of pGH were given at 1400 on d 4 to 6. On d 1 to 3 and 7 to 9 all pigs received sham injections containing sterile saline. Injection and post-injection blood samples were collected on d 4 to 9. The blood was allowed to clot and serum was prepared for use in the bioassays and radioimmunoassays.
Solutions of pGH for injection were prepared by dissolving the pGH in 44 mM NaHCO3, pH 11.5, and then immediately lowering the pH to 9.5 by addition of 1 N HC1. Solutions were prepared on the day of the first injections and filtered through a .22-/1m filter. Protein content of the filtered solution was determined by using the microbiuret method (Itzhaki and Gill, 1964) . The pGH was subjected to SDS polyacrylamide gel electrophoresis in order to assess its homogeneity.
SDS Polyacrylamide Gel Electropboresis. The basic electrophoresis system used for analytical SDS polyacrylamide slab gels was that of Laemmli (1970) ; it consisted of a 3.5% acrylamide stacking gel and a 12% separating gel. Gels were run, stained and destained as described previously Dayton et al., (1981) .
Radioimmunoassays.
Radioimmunoassays (RIA) were done on the individual 6-h serum samples obtained from each pig during the study. Radioimmunoassay kits 6 were used to quantitate the levels of insulin and cortisol in sera. The insulin kit was a homologous RIA for porcine insulin and utilized rabbit anti-porcine insulin antisera. The cortisol kit utilized rabbit anti-cortisol anterisera.
A heterologous radioimmunoassay for porcine growth hormone was used to quantitate levels of pGH in sera. This radioimmunoassay utilized pGH (pituitary, lot AFP 6400) as standard, ieSI-pGH7 as trace and rabbit antibovine growth hormone 7 antisera. The sensitivity of the assay at 95% binding was 5 ng/ml. Serial dilution of porcine serum at 100/.tl, 150 /al, 200/ll and 250/al yielded a curve that was parallel to the pGH standard curve. Recovery of standard in the presence of 200/.tl of serum was 98.6%. The intra-assay variability was 2.95% and inter-assay variability was 9.8%. All samples that were compared with each other in this work were assayed in the same experiment to avoid inter-assay variation.
Somatomedin-C levels in serum were quantified by using a kit 8. Sera were acid-treated (pH 3.5 + 0.3) in 1 M glycine-glycine HCI buffer for 24 h at 37 C prior to assay according to a modification of the procedure of Underwood et al. (1982) . All sera were measured against a human serum somatomedin-C standard (1 U = 36 ng purified SmC). The trace was l~s I-human somatomedin-C, and rabbit anti-human somatomedin-C antisera was used. The intra-assay variability was 5.4%; inter-assay variability was 9.2%. When acidified, swine serum was assayed in the presence of X2Sl.human somatomedin-C standard; 100% recovery of the standard was achieved. A titration of various dilutions (1:4 to 1:20) of swine sera resulted in curves parallel to those obtained with purified somatomedin-C.
Effect of Sera on Muscle Cell Proliferation.
Myogenic cells from the L6 cell line (Yaffe, 1968) were used throughout this study. Cells were incubated at 37 C, 10% CO2 and 100% humidity. Cells were counted by using a Coulter Counter (Model ZB) 9 equipped with a C-1000 Channelyzer 9 .
The bioassay has been described in detail by Kotts et al. (1987) . Briefly, L6 cells were plated at 600/cm 2 (25-cm 2 flasks) in Dulbecco's Modified Eagle Medium (DMEM) containing 10% fetal calf serum (FCS). After 24 h of attachment, the media was removed and cells rinsed with warm (37 C) DMEM without serum (SF media) and test media was applied. After an additional 24-h incubation, the media was replaced with fresh test media and cells were incubated for an additional 48 h. The cells were removed for counting by trypsinization for 5 min at 37 C; the reaction was stopped by adding ice-cold DMEM containing 10% FCS. Cells from each flask were quantitatively transferred to glass tubes on ice. The contents of each tube was counted in triplicate and the counts were averaged. Triplicate flasks were assayed for each serum sample tested and,the results were expressed as the mean number of cells/cm 2/flask + standard error. The intra-assay variability was 2.5% and the inter-assay variability of standardized data was 4.6%. The SF media was used to dilute test sera to the concentrations indicated in the figure legends accompanying the bioassay results.
For each pig, sera collected at 6-h intervals over each 24-h period were combined to form 24-h pools, which were analyzed in the muscle cell culture proliferation bioassay. Our previous studies have shown that 24-h pools formed in this way provide a good measure of the proliferation-promoting activity of serum from a particular pig on a given day.
Statistical Analysis. To establish that the observed increases in proliferation-promoting activity resulted from the pGH injection and were not random daily variations in serum activity, the data obtained from the bioassay were sub-9 Coulter Electronics. jected to analysis of variance. A randomized block design was used, with blocks representing pigs. To test for differences due to pGH injection, the bioassay results from the pre-injection days (1 to 3) were compared with those during (d 4 to 6) and after (d 7 to 9) the injections by using single-degree-of-freedom contrasts on treatments (Snedecor and Cochran, 1967) .
Results

Homogeneity of pGH.
The SDS polyacrylamide gel electrophoresis of the pGH preparation used in this study (figure 1) showed a major band at 21,900 dahons and a minor band at 20,000 dahons, along with several minor bands between 15,000 and 9,000 daltons. The molecular weights of the 21,900-and 20,000-dahon bands correspond to those reported for human growth hormone (Chambach et al., 1973) . The peptides banding between 9,000 and 15,000 daltons may be proteolytic fragments of pGH, or they may be impurities in the preparation. Whatever their origin, any one of these peptides represents an extremely minor contaminant in the pGH preparation.
Addition of pGH Directly to Muscle Cells in
Culture. The pGH preparation was added at various concentrations to media containing 2.5% control swine serum. Radioimmunoassay of the control swine serum showed that it contained 5.56 ng pGH/ml and 2.18 U SmC/ml. Consequently, the contribution of the control swine serum to the final pGH or SmC level in the bioassay media was 6 x 10--12M pGH and 2.58 • 10-t~ SmC (based on molecular weight of 7,600 and 36.1 ng human SmC/U and a molecular weight of 22,000 for pGH). Figure 2 shows the results obtained upon adding increasing amounts of pGH to the media of cultured muscle ceils. Proliferation rate was not significantly affected by 10--9M pGH, while 10-SM pGH or greater resulted in significant increases in cell numbers (10 to 12% above control levels). These results are in agreement with those obtained by others using primary myogenic cultures (Gospodarowicz et al., 1976; Ewton and Florini, 1980; Allen et al., 1983) and of L6 cells (Ewton and Florini, 1980) .
Proliferation-Promoting Activity and Specific Hormone Levels in Sera from pGH-Iniected
Pigs. Figure 3 shows the muscle cell proliferation-promoting activity as well as pGH and SmC levels of sera from a representative pig injected with the low dose of pGH. Although serum pGH was raised from two to three times Figure 1 . 12% SDS polyacrylamide slab gel of porcine growth hormone. Molecular weight standards (stds.) were bovine serum albumin (66,000 ctaltons), ovalbumin (45,000 daltons), trypsinogen (24,000 daltons),/3-1acto-globulin (18,400 daltons) and lysozyme (14,300 daltons).
pre-injection levels, there was no significant change in serum proliferation-promoting activity or SmC level during or after administration of pGH. Similar results were obtained for the other two pigs injected with the low dose of pGH (not shown). When the bioassay data for all three pigs were subjected to analysis of variance, single-degree-of-freedom contrasts revealed that the proliferation-promoting activity of the sera obtained during and after the injection was not different than that of sera obtained before the injection (table 1) . Serum levels of cortisol and insulin also remained unchanged for each pig, ranging from 1.6 to 5.0 /ag/dl and 6.3 to 13.2/aU/ml, respectively.
In contrast to the lack of response to the low dose of pGH, sera from four out of five pigs injected with the high dose of pGH exhibited increased proliferation-promoting activity (figure 4 to 8). Analysis of variance on the bioassay data from all five pigs showed that the treatment effects were highly significant. The single-degree-of-freedom contrasts on treatment revealed that the proliferation-promoting activ- Figure 3. Proliferation-promoting activity, SmC and pGH levels in serum from a representative pig injected with .018 mg pGH-kg-1 .d-t. Injections were given at 1400 on d 4, 5 and 6. In the bioassay, triplicate cultures were assayed in the presence of media containing 3.5% of the 24-h serum pool obtained on the indicated day. Radioimmunoassays were also performed on 24-h serum pools. A--A, pGH; o--% SmC; o--e, cells/cm 2. Figure 2 . Effect of porcine growth hormone on proliferation of myogenic cells. Triplicate cultures received medium containing 2.5% control swine serum plus the indicated amounts of porcine growth hormone. Control cultures (C) received no growth hormone. *Indicates treatments that are different from the control (P<.005).
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ity of sera obtained during and after the pGH injections was significantly higher than the pre-injection levels (table 2) . Additionally, all pigs receiving the high dose showed increases in SmC levels in their serum during and after the injections (figures 4 to 8).
Serum pGH levels were increased approximately 30-fold by 4 h after each pGH injection (1800 samples, figures 4 to 8) and declined to pre-injection Ievels by approximately 16 h after each injection (0600 the next day). Increases in serum SmC levels were observed 6 to 12 h after the increase in serum pGH concentration (10 to 16 h after pGH injection). The magnitude of the SmC response was different for each pig, even though all pigs received the same dose of pGH and attained similar blood levels of pGH 4 h post-injection. The range of increase observed for SmC was from 1.7 (figure 5) to 4 times the pre-injection levels (figure 6). In all pigs, the second and third injections resulted in higher concentrations of serum SmC than the first injection. In two cases (figures 7 and 8), SmC concentrations appeared to increase in a stepwise manner with each successive injection of pGH. A similar stepwise increase in SmC production upon successive injections of human growth hormone into hypopituitary patients has been reported by Copeland et al. (1980) . Serum SmC levels remained high for 2 to 6 d after the last pGH injection. [, 
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Figure 4 (pig 7), 5 (pig 82), 6 (pig 87), 7 (pig 85) and 8 (pig 90). Proliferation-promoting activity, SmC and pGH levels in sera from pigs injected with .143 mg pGH'kg -a -d -l . Injections (indicated by arrows) were given at'1400 on 4, 5 and 6. In the bioassay, triplicate cultures were assayed in the presence of i media containing 3.5% of the 24-h serum pool obtained 300 on the indicated day. Individual 6-h time points pooled o to form 24-h serum pools are indicated by the verticle _~ dotted lines. Radioimmunoassays were performed on 200 ~ sera obtained from each 6-h blood sample.
-1-100 Q.
Insulin and cortisol levels in the sera from high-dose pigs did not change during the treatment period and ranged from 3.8 to 10.6 /aU/ml and 2.0 to 6.9 /2g/dl, respectively (not shown). These levels are in the same ranges as those observed in sera from the pigs which received the low dose of pGH.
It is interesting that sera from pig 90 (figure 8) exhibited little change in proliferation-promoting activity during the experiment, even though increases in radioimmunoassayable SmC were comparable to those observed in the other four pigs. The reasons for this lack of increase are not clear at the present time.
Discussion
Short-term administration of porcine pituitary growth hormone to growing barrows results in a significant increase in the ability of sera from these animals to stimulate proliferation of cultured muscle cells. Two doses of pGH were used: 18 /ag.kg -1.d -I (low dose) and 143 ~ug.kg -1.d -1 (high dose). The low dose was chosen according to Baile et al. (1983) , who reported increased growth rates in swine injected daily with this level of human growth hormone. The high dose was chosen according to Machlin (1972) , who observed increased muscling in swine injected with this level of and Copeland et al. (1980) , who showed induction of SmC in the serum of normal males injected with this dose of human GIt. Consequently, these two doses bracketed the range of doses to date shown to be effective in swine. When added to the cell culture media at physiological concentrations, pGH had no effect on the proliferation of cultured muscle cells. The slight stimulation of proliferation observed at higher concentrations (> 10-gM) is in agreement with the stimulation of AIB uptake into 8-d-old cultures of L6 myotubes exposed to 10-6M bovine Gtt (Ewton and Florini, 1980) , and the slight increase in cell number observed when 10-7M rat GIt was added to primary cultures of rat myoblasts (Florini et al., 1977) . At present, the mechanism through which high levels of growth hormone stimulate proliferation of cultured muscle cells is not known. It is possible, however, that impurities in the GH preparation or biologically active fragments of the GH molecule (Liberti and Miller, 1978) are responsible for these increases in proliferation-promoting activity observed at supraphysiological concentrations of Gtl.
The reason for the failure of the low dose of pGH to stimulate either serum proliferationpromoting activity or SmC levels is not clear. It is possible that the injection period (3 d) was simply not long enough to elicit a physiological response to the relatively low levels of pGH used. In this regard, it is significant that the high pGH dose appeared, in some pigs, to cause a stepwise increase in SmC levels in the sera over the 3-d injection period. This suggests that even in high-dose pigs some time was required to elicit a maximum response to increased pGH levels. Alternatively, this stepwise response may be related to the relatively long half life of SmC in the blood.
Since the pGH preparation injected into the pigs contained peptides of lower molecular weight than pGH, the possibility that these impurities or GH breakdown products are responsible for the responses observed in the high-dose pigs cannot be completely ruled out. However, the fact that serum SmC levels are uniformly increased in high-dose pigs suggest that the observed effects are GH-mediated.
The pGH concentration in the 24-h pooled serum samples from the high-dose pigs on injection days (d 4 to 6) was approximately 100 ng/ml. These serum pools were diluted 29-fold for use in the proliferation bioassay, resulting in a maximum pGH concentration of 10--1~ in the bioassay media. Consequently, the increases in the proliferation-promoting activity observed in these serum pools were not a direct effect of the increased level of pGH in the media because lO-l~ pGH had no effect on proliferation when added directly to the muscle cell cultures (figure 2).
The increased proliferation-promoting activity of sera obtained during and after p(;H injection suggests a possible role for somatomedin or other factors under the control of GH in regulating satellite cell proliferation in vivo. Studies needed to substantiate this hypothesis are limited because of the difficulty of isolating and culturing satellite cells free of major fibroblast contamination.
It is well established that GH stimulates the production of somatomedin (IGF's) by the liver (Phillips et al., 1976) and possibly by other tissues (D'Ercole et al., 1980) . Administration of somatomedin C (IGF-I) to hypophysectomized rats has been reported to restore growth to a level equivalent to that seen with GH replacement (Schoenle et al., 1982) . Additionally, SmC and MSA (multiplication stimulating activity) stimulate the proliferation of myogenic cells in culture Florini, 1980, 1981) . Consequently, it appears likely that the increased levels of SmC/IGF l observed in sera from all high-dose pigs play a role in the increased proliferation-promoting activity of these sera. However, there were instances where increases in SmC levels were not accompanied by any increase in serum proliferation-promoting activity (figure 8), and where sera exhibiting little change in SmC levels changed dramatically in proliferation-promoting activity ( figure 7, d 8) . In addition, sera from pig 87 (figure 6), which exhibited very large increases in SmC levels (from 3.5 U/ml pre-injection to 10 to 13 U/ml during injections), gave only a modest increase in proliferation-promoting activity (13%). Conversely, sera from pig 7 (figure 4), which exhibited little increase in levels of SmC (from approximately 2 U/ml pre-injection to 4 to 5.5 U/ml during injections), showed a 24% increase in proliferation-promoting activity over the injection period. These observations suggest that factors in addition to radioimmunoassayable IGF I may contribute to alterations in proliferation-promoting activity observed in sera during and after pGH injection. For example, IGF II has been reported to increase fourfold in the sera of GH-deficient humans after GH administration (Schalch et al., 1982) . Additionally, inhibitors of IGF-stimulated syn-thesis of DNA in coastal cartilage have been reported in sera from starved, diabetic or hypophysectomized rats (Salmon et al., 1983) , and a protein that inhibits differentiation of L6 myoblasts has been identified in fetal calf serum and in media obtained from BRL cells in culture (Evinger-Hodges et al., 1982) . It is possible that these factors, or others as yet unidentified, are affecting the proliferation-promoting activity of sera in the muscle cell culture bioassay used in this study, one must also consider the possibility that pGH-induced changes in serum somatomedin binding proteins may influence the bioactivity of somatomedin in such a way as to cause the observed divergence between bioassay activity and radioimmunoassayable 1GF I levels in the sera (Meuli et al., 1978; Zapf et al., 1979) . Consequently, this bioassay system will be useful in identifying the specific role of individual factors in the increased proliferation-promoting activity of swine sera in response to pGH treatment.
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